Delivery Order SPE2DR25D2104-SPE2DR26F3PPQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,831.08 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, issued on October 28, 2025, with an ultimate completion date of October 29, 2025, utilizes firm fixed price pricing and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,623.32 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This non-competitive, firm fixed-price delivery order was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $19,427.80 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $8,236.17 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with completion expected by October 28, 2025. This non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $21,622.06 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml quantities. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $31,169.35 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml injections. The contract is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and was awarded on November 5, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- The Defense Logistics Agency has awarded a delivery order valued at $3,481.33 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml quantities. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by October 17, 2025. The award was issued on October 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,932.57 to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitive, non-set-aside award was issued on November 18, 2025, with an ultimate completion date of November 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed-price pricing and operates as a delivery order under a...
- The Defense Logistics Agency awarded a delivery order valued at $1,332.27 to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $41,046.84 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by July 28, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PPQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,820.04 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities. This competitively awarded, firm fixed-price delivery order was executed on November 20, 2025, with an ultimate completion date of November 21, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal medical procurement vendor through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's DLA Troop Support Medical IDC serves military healthcare programs worldwide, supporting customers including the Defense Health Agency and U.S. Coast Guard. Ozempic, a diabetes medication, represents one category within the company's broad therapeutic portfolio delivered under this federal contract vehicle, which demonstrates AmerisourceBergen's capability to fulfill diverse and specialized pharmaceutical supply requirements across multiple therapeutic domains for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/20/25 |